Back to top
more

IQVIA (IQV)

(Delayed Data from NYSE)

$251.55 USD

251.55
1,194,435

+0.76 (0.30%)

Updated Aug 30, 2024 04:00 PM ET

After-Market: $251.48 -0.07 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (73 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Stay Ahead of the Game With IQVIA (IQV) Q4 Earnings: Wall Street's Insights on Key Metrics

Evaluate the expected performance of IQVIA (IQV) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Smart Beta ETF report for FBT

Zacks.com featured highlights include NRG Energy, Darden Restaurants, Allison Transmission Holdings and IQVIA Holdings

NRG Energy, Darden Restaurants, Allison Transmission Holdings and IQVIA Holdings are part of the Zacks Screen of the Week article.

IQV or IDXX: Which Is the Better Value Stock Right Now?

IQV vs. IDXX: Which Stock Is the Better Value Option?

4 GARP Stocks to Scoop up for Maximum Returns

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. NRG, DRI, ALSN and IQV are some stocks that hold promise.

Here's Why You Should Invest in IQVIA Holdings (IQV) Now

IQVIA's (IQV) combined offerings of research and development and commercial services help it to develop trusted relationships.

IQVIA (IQV) Climbs 17% in 3 Months: Here's What to Know

IQVIA (IQV) benefits from revenue growth and disciplined cost management.

IQVIA (IQV) Stock Gains 8% in a Month: Here's What to Know

IQVIA (IQV) aims at market expansion through innovation and service improvements.

Why Is IQVIA (IQV) Up 12.4% Since Last Earnings Report?

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IQVIA (IQV) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

IQVIA Holdings (IQV) Q3 Earnings Top Estimates, Revenues Miss

IQVIA Holdings' (IQV) revenues increase year over year in third-quarter 2023.

IQVIA Holdings (IQV) Q3 Earnings Surpass Estimates

IQVIA (IQV) delivered earnings and revenue surprises of 1.22% and 1.21%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Shockwave Medical (SWAV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Shockwave Medical (SWAV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why IQVIA (IQV) is Poised to Beat Earnings Estimates Again

IQVIA (IQV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

IQVIA (IQV) to Report Q3 Earnings: What's in the Offing?

IQVIA's (IQV) revenues are likely to increase year over year on the back of improving segmental performance.

IQVIA Holdings (IQV) Expected to Beat Earnings Estimates: Should You Buy?

IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for West Pharmaceutical (WST) in Q3 Earnings?

West Pharmaceutical's (WST) third-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.

Indrajit Bandyopadhyay headshot

4 Medical Product Stocks Set to Outpace Q3 Earnings Estimates

Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EW, PODD, DXCM and IQV are poised ahead of their earnings release.

Intuitive Surgical (ISRG) to Post Q3 Earnings: What's in Store?

Intuitive Surgical's (ISRG) third-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.

IQVIA (IQV) and argenx Partner to Advance Autoimmune Care

IQVIA (IQV) and argenx expand collaboration to advance rare autoimmune treatments through innovative pharmacovigilance.

Here's Why Investors Should Retain IQVIA (IQV) Stock Now

An addressable market size and strong healthcare-specific global IT infrastructure boost IQVIA (IQV).

IQVIA (IQV) Up 2.5% Since Last Earnings Report: Can It Continue?

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IQVIA (IQV) Stock Improves 8% in Three Months: Here's How

IQVIA (IQV) aims at market expansion through innovation and service improvements.

IQVIA Holdings' (IQV) Q2 Earnings Beat Estimates, Decline Y/Y

IQVIA Holdings (IQV) second-quarter 2023 revenues improve year over year.